nodes	percent_of_prediction	percent_of_DWPC	metapath
Levobupivacaine—Sensation of heat—Cyclosporine—focal segmental glomerulosclerosis	0.1	0.1	CcSEcCtD
Levobupivacaine—Toxicity to various agents—Cyclosporine—focal segmental glomerulosclerosis	0.0543	0.0543	CcSEcCtD
Levobupivacaine—Paresis—Cyclosporine—focal segmental glomerulosclerosis	0.0425	0.0425	CcSEcCtD
Levobupivacaine—Stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.0408	0.0408	CcSEcCtD
Levobupivacaine—Swelling face—Cyclosporine—focal segmental glomerulosclerosis	0.0326	0.0326	CcSEcCtD
Levobupivacaine—Trauma—Cyclosporine—focal segmental glomerulosclerosis	0.0326	0.0326	CcSEcCtD
Levobupivacaine—Muscle contractions involuntary—Cyclosporine—focal segmental glomerulosclerosis	0.0321	0.0321	CcSEcCtD
Levobupivacaine—Urine abnormality—Cyclosporine—focal segmental glomerulosclerosis	0.028	0.028	CcSEcCtD
Levobupivacaine—Urine analysis abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.0264	0.0264	CcSEcCtD
Levobupivacaine—Fungal infection—Cyclosporine—focal segmental glomerulosclerosis	0.0201	0.0201	CcSEcCtD
Levobupivacaine—Feeling hot—Cyclosporine—focal segmental glomerulosclerosis	0.0198	0.0198	CcSEcCtD
Levobupivacaine—Rigors—Cyclosporine—focal segmental glomerulosclerosis	0.019	0.019	CcSEcCtD
Levobupivacaine—Breast pain—Cyclosporine—focal segmental glomerulosclerosis	0.0178	0.0178	CcSEcCtD
Levobupivacaine—Cardiovascular disorder—Cyclosporine—focal segmental glomerulosclerosis	0.0177	0.0177	CcSEcCtD
Levobupivacaine—Musculoskeletal stiffness—Cyclosporine—focal segmental glomerulosclerosis	0.0173	0.0173	CcSEcCtD
Levobupivacaine—Hyperkalaemia—Cyclosporine—focal segmental glomerulosclerosis	0.0152	0.0152	CcSEcCtD
Levobupivacaine—Urinary incontinence—Cyclosporine—focal segmental glomerulosclerosis	0.015	0.015	CcSEcCtD
Levobupivacaine—Neuropathy—Cyclosporine—focal segmental glomerulosclerosis	0.0146	0.0146	CcSEcCtD
Levobupivacaine—Vascular purpura—Cyclosporine—focal segmental glomerulosclerosis	0.0126	0.0126	CcSEcCtD
Levobupivacaine—Injury—Cyclosporine—focal segmental glomerulosclerosis	0.0123	0.0123	CcSEcCtD
Levobupivacaine—Purpura—Cyclosporine—focal segmental glomerulosclerosis	0.0117	0.0117	CcSEcCtD
Levobupivacaine—Anaphylactoid reaction—Cyclosporine—focal segmental glomerulosclerosis	0.0116	0.0116	CcSEcCtD
Levobupivacaine—Lethargy—Cyclosporine—focal segmental glomerulosclerosis	0.0115	0.0115	CcSEcCtD
Levobupivacaine—Osteoarthritis—Cyclosporine—focal segmental glomerulosclerosis	0.0113	0.0113	CcSEcCtD
Levobupivacaine—Blood creatinine increased—Cyclosporine—focal segmental glomerulosclerosis	0.0105	0.0105	CcSEcCtD
Levobupivacaine—Muscular weakness—Cyclosporine—focal segmental glomerulosclerosis	0.00993	0.00993	CcSEcCtD
Levobupivacaine—Abdominal distension—Cyclosporine—focal segmental glomerulosclerosis	0.0098	0.0098	CcSEcCtD
Levobupivacaine—Dysphagia—Cyclosporine—focal segmental glomerulosclerosis	0.00973	0.00973	CcSEcCtD
Levobupivacaine—Bronchospasm—Cyclosporine—focal segmental glomerulosclerosis	0.00957	0.00957	CcSEcCtD
Levobupivacaine—Sweating increased—Cyclosporine—focal segmental glomerulosclerosis	0.00948	0.00948	CcSEcCtD
Levobupivacaine—Infestation—Cyclosporine—focal segmental glomerulosclerosis	0.00868	0.00868	CcSEcCtD
Levobupivacaine—Infestation NOS—Cyclosporine—focal segmental glomerulosclerosis	0.00868	0.00868	CcSEcCtD
Levobupivacaine—Neuropathy peripheral—Cyclosporine—focal segmental glomerulosclerosis	0.00851	0.00851	CcSEcCtD
Levobupivacaine—Urinary tract infection—Cyclosporine—focal segmental glomerulosclerosis	0.00843	0.00843	CcSEcCtD
Levobupivacaine—Haematuria—Cyclosporine—focal segmental glomerulosclerosis	0.00827	0.00827	CcSEcCtD
Levobupivacaine—Hypoaesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00775	0.00775	CcSEcCtD
Levobupivacaine—Tinnitus—Cyclosporine—focal segmental glomerulosclerosis	0.00726	0.00726	CcSEcCtD
Levobupivacaine—Flushing—Cyclosporine—focal segmental glomerulosclerosis	0.00723	0.00723	CcSEcCtD
Levobupivacaine—Chills—Cyclosporine—focal segmental glomerulosclerosis	0.00699	0.00699	CcSEcCtD
Levobupivacaine—Arrhythmia—Cyclosporine—focal segmental glomerulosclerosis	0.00696	0.00696	CcSEcCtD
Levobupivacaine—Mental disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00682	0.00682	CcSEcCtD
Levobupivacaine—Malnutrition—Cyclosporine—focal segmental glomerulosclerosis	0.00678	0.00678	CcSEcCtD
Levobupivacaine—Flatulence—Cyclosporine—focal segmental glomerulosclerosis	0.00668	0.00668	CcSEcCtD
Levobupivacaine—Tension—Cyclosporine—focal segmental glomerulosclerosis	0.00665	0.00665	CcSEcCtD
Levobupivacaine—Nervousness—Cyclosporine—focal segmental glomerulosclerosis	0.00659	0.00659	CcSEcCtD
Levobupivacaine—Muscle spasms—Cyclosporine—focal segmental glomerulosclerosis	0.00652	0.00652	CcSEcCtD
Levobupivacaine—Vision blurred—Cyclosporine—focal segmental glomerulosclerosis	0.00639	0.00639	CcSEcCtD
Levobupivacaine—Tremor—Cyclosporine—focal segmental glomerulosclerosis	0.00635	0.00635	CcSEcCtD
Levobupivacaine—Anaemia—Cyclosporine—focal segmental glomerulosclerosis	0.00627	0.00627	CcSEcCtD
Levobupivacaine—Agitation—Cyclosporine—focal segmental glomerulosclerosis	0.00623	0.00623	CcSEcCtD
Levobupivacaine—Angioedema—Cyclosporine—focal segmental glomerulosclerosis	0.0062	0.0062	CcSEcCtD
Levobupivacaine—Cough—Cyclosporine—focal segmental glomerulosclerosis	0.00592	0.00592	CcSEcCtD
Levobupivacaine—Convulsion—Cyclosporine—focal segmental glomerulosclerosis	0.00588	0.00588	CcSEcCtD
Levobupivacaine—Hypertension—Cyclosporine—focal segmental glomerulosclerosis	0.00585	0.00585	CcSEcCtD
Levobupivacaine—Arthralgia—Cyclosporine—focal segmental glomerulosclerosis	0.00577	0.00577	CcSEcCtD
Levobupivacaine—Anxiety—Cyclosporine—focal segmental glomerulosclerosis	0.00575	0.00575	CcSEcCtD
Levobupivacaine—Unspecified disorder of skin and subcutaneous tissue—Cyclosporine—focal segmental glomerulosclerosis	0.00573	0.00573	CcSEcCtD
Levobupivacaine—Confusional state—Cyclosporine—focal segmental glomerulosclerosis	0.00558	0.00558	CcSEcCtD
Levobupivacaine—Anaphylactic shock—Cyclosporine—focal segmental glomerulosclerosis	0.00553	0.00553	CcSEcCtD
Levobupivacaine—Oedema—Cyclosporine—focal segmental glomerulosclerosis	0.00553	0.00553	CcSEcCtD
Levobupivacaine—Infection—Cyclosporine—focal segmental glomerulosclerosis	0.0055	0.0055	CcSEcCtD
Levobupivacaine—Nervous system disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00543	0.00543	CcSEcCtD
Levobupivacaine—Skin disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00538	0.00538	CcSEcCtD
Levobupivacaine—Hyperhidrosis—Cyclosporine—focal segmental glomerulosclerosis	0.00535	0.00535	CcSEcCtD
Levobupivacaine—Musculoskeletal discomfort—Cyclosporine—focal segmental glomerulosclerosis	0.00504	0.00504	CcSEcCtD
Levobupivacaine—Insomnia—Cyclosporine—focal segmental glomerulosclerosis	0.00501	0.00501	CcSEcCtD
Levobupivacaine—Paraesthesia—Cyclosporine—focal segmental glomerulosclerosis	0.00497	0.00497	CcSEcCtD
Levobupivacaine—Dyspnoea—Cyclosporine—focal segmental glomerulosclerosis	0.00493	0.00493	CcSEcCtD
Levobupivacaine—Somnolence—Cyclosporine—focal segmental glomerulosclerosis	0.00492	0.00492	CcSEcCtD
Levobupivacaine—Dyspepsia—Cyclosporine—focal segmental glomerulosclerosis	0.00487	0.00487	CcSEcCtD
Levobupivacaine—Decreased appetite—Cyclosporine—focal segmental glomerulosclerosis	0.00481	0.00481	CcSEcCtD
Levobupivacaine—Gastrointestinal disorder—Cyclosporine—focal segmental glomerulosclerosis	0.00478	0.00478	CcSEcCtD
Levobupivacaine—Constipation—Cyclosporine—focal segmental glomerulosclerosis	0.00473	0.00473	CcSEcCtD
Levobupivacaine—Pain—Cyclosporine—focal segmental glomerulosclerosis	0.00473	0.00473	CcSEcCtD
Levobupivacaine—Feeling abnormal—Cyclosporine—focal segmental glomerulosclerosis	0.00456	0.00456	CcSEcCtD
Levobupivacaine—Gastrointestinal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00453	0.00453	CcSEcCtD
Levobupivacaine—Urticaria—Cyclosporine—focal segmental glomerulosclerosis	0.0044	0.0044	CcSEcCtD
Levobupivacaine—Body temperature increased—Cyclosporine—focal segmental glomerulosclerosis	0.00437	0.00437	CcSEcCtD
Levobupivacaine—Abdominal pain—Cyclosporine—focal segmental glomerulosclerosis	0.00437	0.00437	CcSEcCtD
Levobupivacaine—Hypersensitivity—Cyclosporine—focal segmental glomerulosclerosis	0.00408	0.00408	CcSEcCtD
Levobupivacaine—Asthenia—Cyclosporine—focal segmental glomerulosclerosis	0.00397	0.00397	CcSEcCtD
Levobupivacaine—Pruritus—Cyclosporine—focal segmental glomerulosclerosis	0.00392	0.00392	CcSEcCtD
Levobupivacaine—Diarrhoea—Cyclosporine—focal segmental glomerulosclerosis	0.00379	0.00379	CcSEcCtD
Levobupivacaine—Dizziness—Cyclosporine—focal segmental glomerulosclerosis	0.00366	0.00366	CcSEcCtD
Levobupivacaine—Vomiting—Cyclosporine—focal segmental glomerulosclerosis	0.00352	0.00352	CcSEcCtD
Levobupivacaine—Headache—Cyclosporine—focal segmental glomerulosclerosis	0.00347	0.00347	CcSEcCtD
Levobupivacaine—Nausea—Cyclosporine—focal segmental glomerulosclerosis	0.00329	0.00329	CcSEcCtD
